Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?

DSpace Repository

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?

Author: Abdelhak, Ahmed; Hottenrott, Tilman; Morenas-Rodriguez, Estrella; Suarez-Calvet, Marc; Zettl, Uwe K.; Haass, Christian; Meuth, Sven G.; Rauer, Sebastian; Otto, Markus; Tumani, Hayrettin; Huss, Andre
Tübinger Autor(en):
Abdelhak, Ahmed
Published in: Frontiers in Neurology (2019), Bd. 10, Article 280
Verlagsangabe: Frontiers Media Sa
Language: English
Full text: http://dx.doi.org/10.3389/fneur.2019.00280
ISSN: 1664-2295
DDC Classifikation: 610 - Medicine and health
570 - Life sciences; biology
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)